Hyperprolactinemia in a male pituitary androgen receptor knockout mouse model is associated with a female-like pattern of lactotroph development

Circulating prolactin concentration in rodents and humans is sexually dimorphic. Estrogens are a well-characterised stimulator of prolactin release. Circulating prolactin fluctuates throughout the menstrual/estrous cycle of females in response to estrogen levels, but remains continually low in males. We have previously identified androgens as an inhibitor of prolactin release through characterisation of males of a mouse line with a conditional pituitary androgen receptor knockout (PARKO) which have an increase in circulating prolactin, but unchanged lactotroph number. In the present study we aimed to specify the cell type that androgens act on to repress prolactin release. We examined lactotroph-specific, Pit1 lineage-specific and neural-specific conditional AR knockouts, however they did not duplicate the high circulating prolactin seen in the pituitary androgen receptor knockout line, suggesting that the site of androgen repression of prolactin production was another cell type. Using electron microscopy to examine ultrastructure we showed that pituitary androgen receptor knockout male mice develop lactotrophs that resemble those seen in female mice, and that this is likely to contribute to the increase in circulating prolactin. When castrated, pituitary androgen receptor knockout males have significantly reduced circulating prolactin compared to intact males, which suggests that removal of circulating estrogens as well as androgens reduces the stimulation of pituitary prolactin release. However, when expression of selected estrogen-regulated anterior pituitary genes were examined there were no differences in expression level between controls and knockouts. Further investigation is needed into prolactin regulation by changes in androgen-estrogen balance, which has implications not only in the normal sexual dimorphism of physiology but also in diseases such as hyperprolactinemia.

[1]  Pablo G. Cámara,et al.  Single-cell transcriptomic analysis of adult mouse pituitary reveals sexual dimorphism and physiologic demand-induced cellular plasticity , 2020, Protein & Cell.

[2]  A. Sherman,et al.  Cell Type- and Sex-Dependent Transcriptome Profiles of Rat Anterior Pituitary Cells , 2019, Front. Endocrinol..

[3]  B. Ellsworth,et al.  Single-Cell RNA Sequencing Reveals Novel Markers of Male Pituitary Stem Cells and Hormone-Producing Cell Types , 2018, Endocrinology.

[4]  R. Lovell-Badge,et al.  NOTCH activity differentially affects alternative cell fate acquisition and maintenance , 2018, eLife.

[5]  M. den Heijer,et al.  Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment. , 2017, LGBT health.

[6]  Lee B. Smith,et al.  Low-dose tamoxifen treatment in juvenile males has long-term adverse effects on the reproductive system: implications for inducible transgenics , 2017, Scientific Reports.

[7]  Lee B. Smith,et al.  Sertoli Cells Modulate Testicular Vascular Network Development, Structure, and Function to Influence Circulating Testosterone Concentrations in Adult Male Mice , 2016, Endocrinology.

[8]  F. Vaccarino,et al.  Altered expression of neuropeptides in FoxG1-null heterozygous mutant mice , 2015, European Journal of Human Genetics.

[9]  Lee B. Smith,et al.  Pituitary Androgen Receptor Signalling Regulates Prolactin but Not Gonadotrophins in the Male Mouse , 2015, PloS one.

[10]  D. Grattan,et al.  Hypothalamic Control of Prolactin Secretion, and the Multiple Reproductive Functions of Prolactin , 2015 .

[11]  Lee B. Smith,et al.  Targeting of GFP-Cre to the Mouse Cyp11a1 Locus Both Drives Cre Recombinase Expression in Steroidogenic Cells and Permits Generation of Cyp11a1 Knock Out Mice , 2014, PloS one.

[12]  H. Vankelecom,et al.  Regenerative capacity of the adult pituitary: multiple mechanisms of lactotrope restoration after transgenic ablation. , 2012, Stem cells and development.

[13]  P. Chambon,et al.  Identification of estradiol/ERα-regulated genes in the mouse pituitary. , 2011, The Journal of endocrinology.

[14]  P. L. Le Tissier,et al.  Use of a prolactin-Cre/ROSA-YFP transgenic mouse provides no evidence for lactotroph transdifferentiation after weaning, or increase in lactotroph/somatotroph proportion in lactation , 2010, The Journal of endocrinology.

[15]  T. Bisogno.  Endogenous Cannabinoids: Structure and Metabolism , 2008, Journal of neuroendocrinology.

[16]  C. Denef.  Paracrinicity: The Story of 30 Years of Cellular Pituitary Crosstalk , 2007, Journal of neuroendocrinology.

[17]  J. Morris,et al.  Thyrotrophin‐Releasing Hormone, Vasoactive Intestinal Peptide, Prolactin‐Releasing Peptide and Dopamine Regulation of Prolactin Secretion By Different Lactotroph Morphological Subtypes in the Rat , 2007, Journal of neuroendocrinology.

[18]  A. Colao,et al.  Hyperprolactinemia in men , 2003, Endocrine.

[19]  P. Carmeliet,et al.  A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. D. De Paul,et al.  Different Behavior of Lactotroph Cell Subpopulations in Response to Angiotensin II and Thyrotrophin-Releasing Hormone , 1997, Cellular and Molecular Neurobiology.

[21]  N. Ben-Jonathan,et al.  Dopamine as a prolactin (PRL) inhibitor. , 2001, Endocrine reviews.

[22]  S. Mcconnell,et al.  Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures. , 2000, Developmental biology.

[23]  G. Nagy,et al.  Prolactin: structure, function, and regulation of secretion. , 2000, Physiological reviews.

[24]  O. Kretz,et al.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety , 1999, Nature Genetics.

[25]  P. Kelly,et al.  Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. , 1998, Endocrine reviews.

[26]  Sumio Takahashi,et al.  Immuno-Electron Microscopical Study of Prolactin Cells in the Rat--Postnatal Development and Effects of Estrogen and Bromocryptine , 1991 .

[27]  Larry W. Swanson,et al.  Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1 , 1990, Nature.

[28]  J. B. Martin,et al.  Galanin is an estrogen-inducible, secretory product of the rat anterior pituitary. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Nogami,et al.  Fine structural criteria of prolactin cells identified immunohistochemically in the male rat , 1982, The Anatomical record.

[30]  P. Franchimont,et al.  PROLACTIN LEVELS DURING THE MENSTRUAL CYCLE * , 1976, Clinical endocrinology.

[31]  W. Polishuk,et al.  SERUM PROLACTIN AND THE SUPPRESSION OF LACTATION , 1976, British journal of obstetrics and gynaecology.

[32]  B. Freedman,et al.  Oestradiol-17 beta and prolactin levels in rat peripheral plasma. , 1975, British Journal of Cancer.

[33]  J. Meites,et al.  Serum prolactin levels in rats during different reproductive states. , 1970, Endocrinology.

[34]  J. Witherspoon.  The inhibition of lactation during the puerperium by testosterone propionate , 1940 .